正在进行的替米沙坦和雷米普利联合全球终点试验(ONTARGET)中指南推荐的血压目标和心血管和肾脏事件的发生率

{"title":"正在进行的替米沙坦和雷米普利联合全球终点试验(ONTARGET)中指南推荐的血压目标和心血管和肾脏事件的发生率","authors":"W. Elliott","doi":"10.1016/J.YCAR.2012.02.012","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":301861,"journal":{"name":"Yearbook of Cardiology","volume":"70 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":"{\"title\":\"Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)\",\"authors\":\"W. Elliott\",\"doi\":\"10.1016/J.YCAR.2012.02.012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":301861,\"journal\":{\"name\":\"Yearbook of Cardiology\",\"volume\":\"70 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Yearbook of Cardiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/J.YCAR.2012.02.012\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Yearbook of Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/J.YCAR.2012.02.012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}